# Floré

> Floré, built by San Diego biotech Sun Genomics, makes probiotics the slow way: you mail in a stool sample, an accredited lab reads the whole genome of your gut microbiome, and an algorithm trained on tens of thousands of prior formulations builds a supplement matched to the bacteria you actually carry. Founded in 2016 by former Illumina and LabCorp genomicist Sunny Jain, the company sells a subscription that re-tests and re-formulates over time, and has published peer-reviewed research pairing its precision synbiotics with gut and autism-spectrum outcomes.

- **Founded:** 2016
- **Headquarters:** San Diego, California, United States
- **Founders:** Suneer "Sunny" Jain (Founder & CEO)
- **Team size:** Small - roughly 8-30 employees across various trackers
- **Products:** Personalized Probiotics, Gut Microbiome Test, GoodOnes, Floré Clinical / Provider Platform, Autism-focused synbiotics
- **Notable:** Built an accredited CLIA/CAP-grade whole-genome shotgun metagenomics pipeline for the consumer microbiome market., Produced 40,000+ personalized probiotic formulations from 23,000+ sequenced microbiomes., Raised an $8.65M Series A (2020) led by Pangaea Ventures with Danone Manifesto Ventures participating.

## Products & services

- **Personalized Probiotics** — Custom multi-strain probiotic formulas built from a customer's whole-genome microbiome sequencing, delivered as a re-testing subscription that updates the formula over time.
- **Gut Microbiome Test** — At-home stool sampling kit processed via whole-genome shotgun metagenomics in an accredited CLIA/CAP lab, identifying microbes to the species and strain level.
- **GoodOnes** — Pre-formulated, system-matched probiotics offered without requiring an individual test.
- **Floré Clinical / Provider Platform** — A platform letting clinicians order microbiome analysis and prescribe personalized formulations for patients.
- **Autism-focused synbiotics** — Precision synbiotic formulations studied in autism-spectrum cohorts in collaboration with Arizona State University.

## Achievements

- Built an accredited CLIA/CAP-grade whole-genome shotgun metagenomics pipeline for the consumer microbiome market.
- Produced 40,000+ personalized probiotic formulations from 23,000+ sequenced microbiomes.
- Raised an $8.65M Series A (2020) led by Pangaea Ventures with Danone Manifesto Ventures participating.
- Secured a 2023 research and ingredient-sourcing partnership with DSM.
- Published peer-reviewed precision-synbiotic research with Arizona State University in mSystems (2024).

## Latest updates

- **2024-01** — Floré and Arizona State University published a pilot open-label study in mSystems showing precision synbiotics increased gut microbiome diversity and improved GI symptoms in autism-spectrum participants.
- **2023-04** — Sun Genomics discussed precision synbiotics, new gut health tests, and partnerships in NutraIngredients' NutraCast podcast.
- **2023-01** — Announced partnership with DSM Venturing on research and ingredient sourcing.
- **2023-12** — Reported later-stage (Series B) financing per data providers; details undisclosed.

## Links

- Website: https://flore.com
- LinkedIn: https://www.linkedin.com/company/florehealth
- Twitter/X: https://twitter.com/sungenomics
- Instagram: https://www.instagram.com/sungenomics/
- Facebook: https://www.facebook.com/sungenomics/
- TikTok: https://www.tiktok.com/@sungenomics

---

Profile page: https://yespress.io/flore
Published by YesPress — https://yespress.io
Last updated: 2026-07-12